Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies. - Chruścicka-Smaga B; Machaczka A; Szewczyk B; Pilc A (Pharmacological reports : PR, 2023)